A Prospective, Multicentre, Non-interventional, Observational, Post-authorisation Safety Study of Ropeginterferon alfa-2b in Polycythaemia Vera Patients (Besremi-PASS)

24/04/2019
21/02/2025
EU PAS number:
EUPAS29462
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

190913_Ropeg PASS_Protocol_2.0_Redacted

English (328.29 KB - PDF) View document
Updated protocol

Ropeg PASS_Protocol_2.3_26Apr2022_clean_Redacted

First published: 22/02/2024
English (348.94 KB - PDF) View document
Study results
Study report
Other information
Study, other information

Besremi-PASS_Protocol Redacted_V2.2_16Jun2020

English (335.13 KB - PDF) View document